Burst CME: Managing Fluid Overload in Patients With Chronic Kidney Disease

Thanks for your interest in this podcast. Please read this important program information before listening.

Episode Description

In this podcast, expert Suneel Udani, MD, discusses the management of chronic kidney disease (CKD) and CKD-associated fluid overload, including an overview of treatment guidelines and various available therapies.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Discuss evidence regarding current and emerging therapies to manage fluid overload in patients with CKD and cardiac comorbidities
• Develop treatment plans for fluid overload in patients with CKD and cardiac comorbidities

Acknowledgment of Educational Grant Support

This activity is supported by an educational grant from scPharmaceuticals, Inc.

Chair:

Suneel Udani, MD

Consulting Physician
Nephrology Associates of Northern Illinois and Indiana (NANI)
Hinsdale, Illinois, United States

Consultant: Amgen, Boehringer Ingelheim International GmbH, Calliditas Therapeutics, George Clinical, Novartis, scPharmaceuticals, Travere Therapeutics; Speakers Bureau: Amgen, Boehringer Ingelheim International GmbH, Novartis, Travere Therapeutics; Other: Apellis Pharmaceuticals, AstraZeneca, Bayer, Dimerix, ENYO, Goldfinch Bio, Mallinckrodt Pharmaceuticals, Novartis, Travere Therapeutics, Vertex Pharmaceuticals Incorporated.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.

This podcast was developed by PER® editorial staff based on an online activity developed with this faculty. The narration in this podcast is AI generated.

Release Date

August 29, 2025

Expiration Date

August 29, 2026

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.